Skip to content

CorMedix CRMD Net margin

Net margin at other companies

Pfizer logo
PfizerPFE
15.7%
Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9%+0.2pp
ITG
Integer HoldingsITGR
7.6%+3.2pp
IAR
Integra LifeSciencesIART
-30.1%
MiMedx Group logo
MiMedx GroupMDXG
7.9%-3.5pp

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on trailing twelve months.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's net margin?
CorMedix (CRMD) reported net margin of 45.2% in Q1 2026.
What is the long-term trend for CorMedix's net margin?
Over 3 years (2020 to 2025), CorMedix's net margin has grown at a -82.2% compound annual growth rate (CAGR), from -9,207.7% to 52.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.